SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Phaarmasia - Quaterly Results

13 Feb 2024 Evaluate
The sales slipped to Rs. 50.84 millions, down -35.99% for the December 2023 quarter as against Rs. 79.42 millions during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -5.65 millions as compared to Net Loss of Rs. -5.91 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 improved to -4.33% as compared to -5.25% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 50.84 79.42 -35.99 206.04 199.86 3.09 274.90 172.16 59.68
Other Income 1.25 1.14 9.65 4.67 3.75 24.53 5.16 4.70 9.79
PBIDT -4.33 -5.25 -17.52 -6.85 -9.56 -28.35 -10.27 -12.65 -18.81
Interest 0.25 0.05 400.00 0.39 0.13 200.00 0.45 0.04 1025.00
PBDT -4.58 -5.30 -13.58 -7.24 -9.69 -25.28 -10.72 -12.69 -15.52
Depreciation 0.84 0.64 31.25 2.58 1.91 35.08 3.60 2.92 23.29
PBT -5.42 -5.94 -8.75 -9.82 -11.60 -15.34 -14.32 -15.61 -8.26
TAX 0.23 -0.03 -866.67 0.10 0.05 100.00 -1.73 -0.15 1053.33
Deferred Tax 0.23 -0.03 -866.67 0.10 0.05 100.00 -1.73 -0.15 1053.33
PAT -5.65 -5.91 -4.40 -9.92 -11.65 -14.85 -12.59 -15.46 -18.56
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) -8.52 -6.61 28.84 -3.32 -4.78 -30.50 -3.74 -7.35 -49.16

Phaarmasia Share Price

113.80 1.80 (1.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×